These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8491077)

  • 1. Heparin and warfarin therapy after acute myocardial infarction.
    Yedinak KC; Sproat TT
    Clin Pharm; 1993 Mar; 12(3):197-215. PubMed ID: 8491077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of acute thromboembolism with heparin and warfarin.
    Carter BL
    Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction.
    Seljeflot I; Hurlen M; Arnesen H
    J Thromb Haemost; 2004 May; 2(5):726-30. PubMed ID: 15099277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
    Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
    Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for antithrombotic therapy after myocardial infarction.
    Vaitkus PT
    Heart Dis Stroke; 1994; 3(1):24-8. PubMed ID: 8137061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.
    Jeddy AS; Gleason BL
    Ann Pharmacother; 2003 Oct; 37(10):1502-5. PubMed ID: 14519047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
    Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
    Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin in the treatment and secondary prevention of myocardial infarction. A critical review of the main trials].
    Kher A; Samama M; Haïat R
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1581-6. PubMed ID: 1662479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy impact on prognosis after twelve months of first acute myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Nov; 19(11):1103-19. PubMed ID: 11201627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
    Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
    Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.